BCL2 and central nervous system cancer: Treatment of glioma cells with ATB-737 and TRAIL has proved to be effective to induce apoptosis by cleaving Bid into tBid, activating caspase-8, and facilitating the accumulation of tBid on the mitochondrial membrane after ABT-737 neutralized Bcl-2 and Bcl-xL.